H Suemori-Matsushita

Learn More
PURPOSE The purpose of the study is to determine the optimum regimen of intraoperative administration of mitomycin as an adjunct to trabeculectomy. METHODS Of 11 patients with primary open-angle glaucoma, 22 eyes that had not undergone any surgical intervention were included. In each patient, one eye was randomly allocated to a mitomycin 0.2-mg group and(More)
We prospectively investigated the postoperative intraocular pressure (IOP) level, visual prognosis, and complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma. The subjects were 42 eyes of 29 patients who underwent surgery with 0.2 mg mitomycin C as an adjunct and were followed for 12-30 months (mean: 20.6 months). The(More)
PURPOSE A prospective investigation of the postoperative intraocular pressure level, visual function changes, and postoperative complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma. PATIENTS AND METHODS Thirty-one patients (31 eyes) who underwent trabeculectomy with 0.4 mg/ml mitomycin C were studied. The preoperative(More)
We retrospectively studied incidence, prognosis and predictive factors of hypotonous maculopathy following trabeculectomy with adjunctive mitomycin C. The subjects were 208 cases (208 eyes) with various types of glaucoma with clear media, who were followed up for at least three months postoperatively. The follow up periods ranged from 3 to 44 months with a(More)
  • 1